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The concept that materna,! hypoglycemia, way have deJLeterious
effects on the fetus has been based on th.e clinica,! ob^ervation of
lowered birth weights of these infants and lowe^ed £ t Q Ä and motor
scores of infants of mothers with ketonuria,(l) * An. incjrease in
perinatal mortality has been also reported among hypoglycemic
mothers who have evidenced lower than expected excretion öf egtriol
(2). The concern about possible adverse effects of materna.1 hypo~
glycemia on fetal development has been increasing äs the contempo~
rary management of diabetes mellitus in pregna;ncy, call$ for a
rigid maintenance of maternal blood sugär in the euglycemic ränge,
The purpose of this presentation is to review the mechanisms by
which maternal and hence fetal hypoglyceöaa cpuld be adyer^e tö
fetal development.
In the fetus, glucose is the mäin source pf energy for meta^
bolic processes and the principle precursör of neutral £a,t$ and
glycogen. It can be calculated that between the 35th and 40th week
of gestation when fat deposition is at its maximum,, the total glu-
cose utilization per kilogram of fetal body mäss^ i.s about 8 mg per
minute. Assuming a placental utilization of glucose of 7~8 mg per
minute, and an intervillous space and villous capillary flow rates
of 150 ml per kilogram of fetal mass per minute, the concentration
difference between uterine artery and umbilical artery is 12 mg%.
Such calculations are in close agreement with actua.1 mea&urements
of fetal and maternal glucose concentration during labor (e.g. 72mg%
and 82 mg% respectively)(3). There are no data available in the
human regarding the concentration of dextrose in fetal blood neces'-
sary to maintain fetal functions within limits of norm. Typically
during the second to ninfih hour of postnatal age, the mean value of
plasma glucose is about 50 mg%, which is about 20 mg% less than that
observed in fetuses of euglycemic mothers(4). During the first
three (3) days postnatally, äs many äs five (5%) percent of apparent-
ly normal newborns have plasma glucose concentrati.ons of less than
35 mg%, without exhibiting clinical signs of hypoglycemia(4).
Assuming that the tolerance of the fetus to hyppglycemia is not
less than that of the newborn, it can be projected that adequate
supply of glucose to the fetus \rould be ensured äs long äs maternal
arterial glucose concentration exceeds 47 mg%. This value has been
derived by adding to the low normal neonatal glucose values, the
calculated difference between glucose concentration in the uterine
artery and in the umbilical artery. Most individuals are pvertly
syptomatic at plasma glucose concentrations below 50 mg%; hence it
is unlikely that such relative states of maternal hypoglycemia, at
least in the wakeful stäte, would remain undetected,
From the above considerations, it can be inferred that fetal
glucose concentration in the asynptomatic mother is substaiitially
above that required to meet fetal metabolic rieeds, and that sub-
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strate deprivation is not a likely cause of adverse sequelae to the
fetus. The impact of severe maternal hypoglycemia äs might occur
with transient maternal hyperinsulinemia is expected to be attenu-
ated due to the ability of the fetus to mobilize its own glycogen
Stores.
If it is agreed that fetal hypoglycemia is unlikely through
its direct effect to elicit deleterious consequences, several of
its indirect actions deserve close scrutiny äs causative factors.
They are: ketonemia, hypoinsulinemia, and increased release of
catecholamines from maternal Stores.
Maternal ketonemia has been associated with lowering of neuro-
logic and intellectual functions in the offsprings irrespective of
the underlying condition and the maternal blood sugar level(l).
These data have been generally interpreted äs supportive of the
contention that maternal and hence fetal ketonemia adversely effect
the development of the central nervous System. More recent data
have, however, challanged the validity of this Interpretation. It
has been demonstrated that endogenous ketones are readily oxydized
by brain tissue of the fetus and, at least theoretically they repre-
sent äs suitable a source of energy äs glucose (5). We propose
that ketonemia is an associated variable in the causation of neuro-
logic injury, the primary being hypoxia caused by impaired perfus-
ion of the uterus, occuring äs a result of the maternal state re-
sulting inxketonemia,
Due to the well recognized role of insulin in fetal growth,
hypoinsulinemia, whieh is likely to result from fetal hypoglycemia,
may play an important role in alterating the normal growth pattern
of the fetus. In contrast to the previously held view that insulin
exerted its effect only on the adipocytes, it is now known that in-
sulin can differentially affect various fetal organs and their
sizes(6). Although certain amirio acids can increase the release of
insulin from fetal pancreäs, it is proposed that low glucose levels
of the fetus would lead to relative hypoinsulinemia with the re-
sultant reduction of somatic growth and subnormal aceumulation of
neutral fats and glycogen(7).
Such newborns, although normocephalic, would be classified äs
low birth weight, and would experience in the neonatal period a
number pf difficulties such äs hypothermia and hypoglycemia. The
clinical findings of such newborns are explained on the basis of
high thermal conductance due to absence of insula,tion by subcutane-
ous fat, increase in energy transformation rates through hemothermal
mechanisms, and low glycogen content of the liver.
Maternal hypoglycemia causes activation of the adrenergic
nervous System resulting in both norepinephrine and epinephrine re-
lease. It has been demonstrated that in patients with diabetes
mellitus, hypoglycemia doubles the plasma concentration of nore-
pinephrine (8) . Exogenous äs well äs indogenous norepinephrine
causes marked reduction in fetal oxygenation secondary to alpha
adrenergically mediated vasoconstriction in the vasculature supply-
ing the uterus. A similar effect has also been noted following ad-
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ministration of epinephrine(9), A chronic or intermittant reduct^
ion in intervillous space perfuslon could lead to a, pictüre of
partial prolonged fetal hypoxia without hypercarbia or acido^is.
We conclude that fetal hypoglycemia and ketonemia per se, re~
sulting from maternal hypoglycemia, is unlikely to have an adverse
effect on fetal development in man, Impaired neurologic performance
of children born to hypoglycemia and ketonemic mothers is more
likely to be brought about by impaired fetal oxygenation secondary
to adrenergically mediated vasoconstriction in uterine circulation«
More subtle aberrations from normal development, and reduction in
birth weight of these infants could be accounted for by hypoinsuliiv·
emia of the fetus, The role of other substauce^, that might be pre-
sent in abnormal concentrations in fetuses öf hypoglyeemic mothers,
such äs glucagon or growth hormone, still remains to be elucidated,
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